Experimental treatment of Ebola virus disease with brincidofovir by Dunning, J, Kennedy, S, Antierens, A, Whitehead, J, Ciglenecki, I, Carson, G, Kanapathipillai, R, Castle, L, Howell-Jones, R, Pardinaz-Solis, R, Grove, J, Scott, J, Lang, T, Olliaro, P, Horby, P

“…Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of agents that should be prioritised for clinical evaluation in patients with Ebola virus disease (EVD) during the West African epidemic.In this single-arm phase 2 trial conducted in Liberia, patients with laboratory-confirmed EVD (two months of age or older, enrolment bodyweight ≥50 kg) received oral brincidofovir 200 mg as a loading dose on day 0, followed by 100 mg brincidofovir on days 3, 7, 10, and 14. …”

Toremifene interacts with and destabilizes the Ebola virus glycoprotein by Zhao, Y, Ren, J, Harlos, K, Jones, D, Zeltina, A, Bowden, T, Padilla-Parra, S, Fry, E, Stuart, D

“…Ebola viruses (EBOVs) are responsible for repeated outbreaks of fatal infections, including the recent deadly epidemic in West Africa. …”

Killing Ebola: The Militarization of US Aid in Liberia by Calcagno, D

“…In Liberia, the security-development nexus strongly emphasized the security side when Ebola became an international crisis with potential for global risk in 2014. …”

Toremifene interacts with and destabilizes the Ebola virus glycoprotein. by Zhao, Y, Ren, J, Harlos, K, Jones, D, Zeltina, A, Bowden, T, Padilla-Parra, S, Fry, E, Stuart, D

“…Ebola viruses (EBOVs) are responsible for repeated outbreaks of fatal infections, including the recent deadly epidemic in West Africa. …”

Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse by Sophie J. Smither, Lin S. Eastaugh, Mark S. Lever

Subjects: “…Ebola virus…”
Get full text

Tolerance and Persistence of Ebola Virus in Primary Cells from <i>Mops condylurus</i>, a Potential Ebola Virus Reservoir by Marcel Bokelmann, Uwe Vogel, Franka Debeljak, Ariane Düx, Silke Riesle-Sbarbaro, Angelika Lander, Annette Wahlbrink, Nicole Kromarek, Stuart Neil, Emmanuel Couacy-Hymann, Joseph Prescott, Andreas Kurth

Subjects: “…Ebola virus…”
Get full text

Patterns of demand for non-Ebola health services during and after the Ebola outbreak: panel survey evidence from Monrovia, Liberia by Morse, Benjamin Sherman, Grépin, Karen A., Blair, Robert A., Tsai, Lily L.

“…Introduction: The recent Ebola virus disease (EVD) outbreak was unprecedented in magnitude, duration and geographic scope. …”
Get full text
Get full text

Willingness to pay for an Ebola vaccine during the 2014–2016 ebola outbreak in West Africa: Results from a U.S. National sample by Julia E. Painter, Michael E. von Fricken, Suyane Viana de O. Mesquita, Ralph J. DiClemente

Subjects: “…ebola…”
Get full text

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge by Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, Winston Chiu, Thomas Vercruysse, Ji Ma, Hendrik Jan Thibaut, Johan Neyts, Lorena Sanchez-Felipe, Kai Dallmeier

“…Abstract Ebola virus (EBOV) and related filoviruses such as Sudan virus (SUDV) threaten global public health. …”
Get full text

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo. by Anna Bratcher, Nicole A Hoff, Reena H Doshi, Adva Gadoth, Megan Halbrook, Patrick Mukadi, Kamy Musene, Benoit Ilunga-Kebela, D'Andre Spencer, Matthew S Bramble, David McIlwan, J Daniel Kelly, Daniel Mukadi, Placide Mbala Kingebeni, Steve Ahuka, Emile Okitolonda-Wemakoy, Jean-Jacques Muyembe-Tamfum, Anne W Rimoin

“…<h4>Background</h4>Ebola virus (EBOV) is a zoonotic filovirus spread through exposure to infected bodily fluids of a human or animal. …”
Get full text

A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea. by Romain Palich, Jean-Luc Gala, Frédéric Petitjean, Susan Shepherd, Olivier Peyrouset, Bing M Abdoul, Moumouni Kinda, Christine Danel, Augustin Augier, Xavier Anglaret, Denis Malvy, Nicole Blackwell, ALIMA N’zérékoré Ebola Treatment Center medical group

Get full text

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study by Sissoko, D, Duraffour, S, Kerber, R, Kolie, J, Beavogui, A, Camara, A, Colin, G, Rieger, T, Oestereich, L, Pályi, B, Wurr, S, Guedj, J, Nguyen, T, Eggo, R, Watson, C, Edmunds, W, Bore, J, Koundouno, F, Cabeza-Cabrerizo, M, Carter, L, Kafetzopoulou, L, Kuisma, E, Michel, J, Patrono, L, Rickett, N, Singethan, K, Rudolf, M, Lander, A, Pallasch, E, Bockholt, S, Rodríguez, E, Di Caro, A, Wölfel, R, Gabriel, M, Gurry, C, Formenty, P, Keïta, S, Malvy, D, Carroll, M, Anglaret, X, Günther, S

“…<br/><strong>Background: </strong>By January, 2016, all known transmission chains of the Ebola virus disease (EVD) outbreak in west Africa had been stopped. …”

Comparative performance of four rapid Ebola antigen-detection lateral flow immunoassays during the 2014-2016 Ebola epidemic in West Africa by Wonderly, B, Jones, S, Gatton, M, Barber, J, Killip, M, Hudson, C, Carter, L, Brooks, T, Simpson, A, Semper, A, Urassa, W, Chua, A, Perkins, M, Boehme, C

“…The study was performed in an Ebola Treatment Centre laboratory involved in EVD testing in Sierra Leone. …”

The Ebola epidemic: a transformative moment for global health by Stephen B Kennedy, Richard A Nisbett

Get full text

Current and Future Diagnostic Tests for Ebola Virus Disease by Bharti Singh, Advaita Ganguly, Hoon H Sunwoo

“…Ebola virus disease (EVD) is a major public health concern with a high mortality rate in infected individuals. …”
Get full text

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine by Francesco Santoro, Alessia Donato, Simone Lucchesi, Sara Sorgi, Alice Gerlini, Marielle C. Haks, Tom H. M. Ottenhoff, Patricia Gonzalez-Dias, VSV-EBOVAC Consortium, VSV-EBOPLUS Consortium, Helder I. Nakaya, Angela Huttner, Claire-Anne Siegrist, Donata Medaglini, Gianni Pozzi

Get full text

Sources of Mapping used in Humanitarian Emergencies: The Case of Ebola by Barra Martínez José Antonio, Morales-Yago Francisco José, de Lázaro-Torres María Luisa

Subjects: Get full text

China's Response to the 2014 Ebola Outbreak in West Africa by Yanzhong Huang

Subjects: Get full text

Sequence optimized diagnostic assay for Ebola virus detection by Jeffrey W. Koehler, Christopher P. Stefan, Adrienne T. Hall, Korey L. Delp, Aileen E. O’Hearn, Cheryl L. Taylor-Howell, Nadia Wauquier, Randal J. Schoepp, Timothy D. Minogue

“…Limited genomic sequences for rare pathogens such as Ebola virus (EBOV) can negatively impact assay performance due to undiscovered genetic diversity. …”
Get full text

Are we prepared for Ebola and other viral haemorrhagic fevers? by Allen C. Cheng, Heath Kelly

Get full text